Literature DB >> 10365738

Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke.

M D McColl1, E A Chalmers, A Thomas, A Sproul, C Healey, I Rafferty, R McWilliam, P Eunson.   

Abstract

Ischaemic stroke is a rare occurrence in children and in a proportion of cases the aetiology remains unknown. We have investigated the role of thrombophilia in the aetiology of this condition. Of 50 cases identified at two centres, 37 were available for detailed haematological analysis. No cases were identified with deficiencies of antithrombin, protein C or protein S. One case had elevated IgG anticardiolipin antibodies at low titre. The prevalence of the prothrombin 20210 G-->A mutation, factor V Leiden (FVL) mutation and the C677T mutation in the MTHFR gene was compared in cases to that observed in random unselected cord blood controls. The odds ratio for stroke was not significantly increased in carriers of the prothrombin mutation (OR 1.2; 95% CI 0.1-10.7), FVL (OR 2.5; 95% CI 0.5-13.5), or the C677T mutation (OR 1.7; 95% CI 0.6-4.5). Our findings suggest that thrombophilia may not play a significant role in the aetiology of stroke in children, although a large prospective study is required to investigate this area further.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365738

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

Review 2.  Thrombophilia and first arterial ischaemic stroke: a systematic review.

Authors:  S Haywood; R Liesner; S Pindora; V Ganesan
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

3.  Treatment and prevention of cerebrovascular disorders in children.

Authors:  John Kylan Lynch; Steven Pavlakis; Gabrielle Deveber
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

Review 4.  Antithrombotic drug treatment of pediatric patients with ischemic stroke.

Authors:  Ulrike Nowak-Göttl; Ronald Sträeter; Guillaume Sébire; Fenella Kirkham
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 6.  Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Gian Luca Salvagno; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-02-10       Impact factor: 2.300

Review 7.  Cerebrovascular disorders in children.

Authors:  John Kylan Lynch
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

8.  The TT genotype of methylenetetrahydrofolate reductase 677C>T polymorphism increases the susceptibility to pediatric ischemic stroke: meta-analysis of the 822 cases and 1,552 controls.

Authors:  Beata Sarecka-Hujar; Ilona Kopyta; Karolina Pienczk-Reclawowicz; Daniel Reclawowicz; Ewa Emich-Widera; Ewa Pilarska
Journal:  Mol Biol Rep       Date:  2012-05-04       Impact factor: 2.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.